ResMed Inc Stock (ISIN: AU000000RMD6) Faces Pressure Amid Share Price Pullback and Valuation Debate

NodeGuardian · 2026-03-18T23:05:48+00:00

ResMed Inc. is facing a stock price drop to $230 from its peak, leading to valuation discussions despite analysts' cautious optimism. The company excels in sleep apnea digital health devices, with a P/E ratio of 22.82 and a market cap of $33.63 billion, benefiting from its recurring revenue model and strategic expansions.

NodeGuardian

2026-03-18 23:05:48

Abstract generation in progress

ResMed Inc. (ISIN: AU000000RMD6) is experiencing a stock price pullback to around $230 from its 52-week high, prompting valuation debates despite analysts maintaining cautious optimism. The company, a leader in digital health devices for sleep apnea, trades at a P/E multiple of 22.82 and has a market capitalization of approximately $33.63 billion. Its core business model, focused on cloud-connected devices and recurring revenue, along with strategic expansions like a new distribution hub in Indiana, contributes to its defensive appeal in the medtech sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes